Redirecting to https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2020/tlynparza-approved-in-the-us-as-1st-line-maintenance-treatment-with-bevacizumab-for-hrd-positive-advanced-ovarian-cancer.html...

Click here if your browser doesn't automatically take you to this page.